IP Library › Granted Patent US 12,251,547
Granted Patent B2
US 12,251,547 · App. 18/760,391 · Granted Mar 18, 2025

Medicament delivery device with use indicator

Inventors: Stephan Riedel (Frankfurt am Main, DE); Steffen Raab (Frankfurt am Main, DE); Kerstine Hemmann (Frankfurt am Main, DE); Michael Caspers (Frankfurt am Main, DE); Katja Hoerhold (Frankfurt am Main, DE); Daniel Kerkow (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/5086A61M5/3202A61M2005/3267A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,547
App. No.
18/760,391
Granted
Mar 18, 2025
Kind
B2
Abstract

Described is a medicament delivery device comprising a case adapted to hold a container with a medicament and having a needle, a needle sleeve telescopically coupled to the case and having a first extended position relative to the case in which the needle is covered, a retracted position relative to the case in which the needle is exposed, and a second extended position relative to the case in which the needle is covered, a first indicia disposed on the needle sleeve which is visible in the first extended position and the second extended position, and a second indicia disposed on the needle sleeve and not visible in the first extended position and visible the second extended position.

Claims (44)

1. A method comprising:

moving a sleeve of an auto-injector relative to a housing of the auto-injector from (i) a first sleeve position in which a first indicia on an outer surface of the sleeve is in a first indicia position to indicate a first status of the auto-injector to (ii) a second sleeve position in which the first indicia is in a second indicia position to indicate a second status of the auto-injector, the first indicia comprising a green color and being viewable from an exterior of the auto-injector when the first indicia is in the first and second indicia positions;

depressing a button at a proximal end of the auto-injector to allow (i) a distal end of a needle of a syringe to be exposed from a distal end of the housing and (ii) a plunger to distally drive a stopper within the syringe to dispense a medicament from the syringe; and

locking the sleeve in the second sleeve position such that after the medicament has been dispensed from the syringe, the first indicia remains in the second indicia position to permanently indicate the second status of the auto-injector,

wherein the auto-injector comprises a second indicia axially offset from the first indicia, the second indicia comprising a symbol or a graphic of a second color different than the green color and being viewable from the exterior of the auto-injector at least when the first indicia is in the second indicia position.

2. The method of claim 1 , comprising directly touching the sleeve to move the sleeve from the first sleeve position to the second sleeve position.

3. The method of claim 1 , wherein the second color is red.

4. The method of claim 1 , wherein the symbol or the graphic of the second indicia is a second symbol or a second graphic, and the first indicia comprises a first symbol or a first graphic.

5. The method of claim 1 , wherein the first status of the auto-injector represents an initial state of the auto-injector before the medicament has been dispensed from the syringe.

6. The method of claim 5 , wherein the second status of the auto-injector represents a used state of the auto-injector.

7. The method of claim 1 , wherein the first indicia is disposed on a proximal portion of the sleeve and extends proximally from an edge between a distal portion of the sleeve and the proximal portion.

8. The method of claim 7 , wherein an axial length of the proximal portion is greater than an axial length of the distal portion.

9. The method of claim 8 , wherein an axial length of the first indicia is shorter than the axial length of the proximal portion of the sleeve.

10. The method of claim 1 , wherein the second indicia is disposed on the sleeve.

11. A method comprising:

moving a sleeve of an auto-injector relative to a housing of the auto-injector from (i) a first sleeve position in which a first indicia on an outer surface of the sleeve is in a first indicia position to indicate a first status of the auto-injector to (ii) a second sleeve position in which the first indicia is in a second indicia position to indicate a second status of the auto-injector, the first indicia comprising a green color and being viewable from an exterior of the auto-injector when the first indicia is in the first and second indicia positions;

depressing a button at a proximal end of the auto-injector to allow a distal end of a needle of a syringe to be exposed from a distal end of the housing; and

after depressing the button, distally moving a plunger relative to the syringe to dispense a medicament from the syringe into an injection site,

wherein the auto-injector is configured to lock the sleeve in the second sleeve position such that the first indicia remains in the second indicia position after the medicament has been dispensed from the syringe to indicate the second status of the auto-injector, and the first status of the auto-injector represents a first state of the auto-injector before the medicament has been dispensed from the syringe.

12. The method of claim 11 , wherein the auto-injector comprises a second indicia axially offset from the first indicia.

13. The method of claim 12 , wherein the second indicia comprises a symbol or a graphic of a second color different than the green color.

14. The method of claim 13 , wherein the second color is red.

15. The method of claim 12 , comprising viewing the first and second indicias from the exterior of the auto-injector.

16. The method of claim 11 , wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

17. The method of claim 11 , wherein the first state of the auto-injector represents an initial state of the auto-injector, and a second state of the auto-injector represents a used state of the auto-injector.

18. A method comprising:

moving a sleeve relative to a housing of an auto-injector from (i) a first sleeve position in which a first indicia on an outer surface of the sleeve is in a first indicia position to indicate a first status of the auto-injector to (ii) a second sleeve position in which the first indicia is in a second indicia position to indicate a second status of the auto-injector, the first indicia comprising a first color and being viewable from an exterior of the auto-injector when the first indicia is in the first and second indicia positions; and

depressing a button at a proximal end of the auto-injector to allow a distal end of a needle of a syringe to be exposed from a distal end of the housing and a plunger to distally drive a stopper within the syringe to dispense a medicament from the syringe into an injection site,

wherein the auto-injector comprises a second indicia comprising a symbol or a graphic of a second color different than the first color and being viewable from the exterior of the auto-injector at least when the first indicia is in the second indicia position.

19. The method of claim 18 , comprising directly touching the sleeve to move the sleeve from the first sleeve position to the second sleeve position.

20. The method of claim 18 , wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

21. The method of claim 18 , wherein the symbol or the graphic of the second indicia is a second symbol or a second graphic, and the first indicia comprises a first symbol or a first graphic different from the second symbol or graphic.

22. The method of claim 18 , wherein the first color is green.

23. The method of claim 18 , wherein the second color is red.

24. A method comprising:

moving a sleeve of an auto-injector relative to a housing of the auto-injector from (i) a first sleeve position in which a first indicia on an outer surface of the sleeve is in a first indicia position to (ii) a second sleeve position in which the first indicia is in a second indicia position, the first indicia comprising a first color and being viewable from an exterior of the auto-injector; and

depressing a button at a proximal end of the auto-injector to allow a distal end of a needle of a syringe to be exposed from a distal end of the housing and a plunger to distally drive a stopper within the syringe to dispense a medicament from the syringe,

wherein the auto-injector comprises a second indicia comprising a symbol or graphic of a second color and being viewable from the exterior of the auto-injector.

25. The method of claim 24 , wherein the first color is green.

26. The method of claim 25 , wherein the auto-injector is configured such that when the sleeve is in the first sleeve position, the first and second indicias are indicative of an initial state of the auto-injector.

27. The method of claim 26 , wherein the auto-injector is configured such that when the sleeve is in the second sleeve position, the first and second indicias are indicative of a used state of the auto-injector.

28. The method of claim 24 , comprising dispensing the medicament from the auto-injector, the medicament comprising a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

29. The method of claim 24 , wherein the second color is different from green.

30. The method of claim 24 , wherein the first indicia is viewable from the exterior of the auto-injector when the first indicia is in the first and second indicia positions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2024
From: RIEDEL, STEPHAN; RAAB, STEFFEN; HEMMANN, KERSTINE; CASPERS, MICHAEL; HOERHOLD, KATJA; KERKOW, DANIEL
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 068045/0434 →
Priority Claims (1)
EP 12188585 · Oct 15, 2012 · regional
Continuity (5)
Continuation 18662414 · May 13, 2024
Continuation 17000870 · Aug 24, 2020
Continuation 16164774 · Oct 18, 2018
Continuation 14435564
Related Publication 20240350750A1 · Oct 24, 2024
References Cited (54)
US 5591189A · Yoon · 1997 [cited by applicant]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9216256B2 · Olson et al. · 2015 [cited by applicant]
US 9233213B2 · Olson et al. · 2016 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10173017B2 · Riedel et al. · 2019 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 10569019B2 · Hirschel et al. · 2020 [cited by applicant]
US 10799647B2 · Hostettler et al. · 2020 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11383044B2 · Tschirren et al. · 2022 [cited by applicant]
US 11452821B2 · Lafever et al. · 2022 [cited by applicant]
US 11904153B2 · Riedel et al. · 2024 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20090227956A1 · Emmott et al. · 2009 [cited by applicant]
US 20090259178A1 · Brechbuehler · 2009 [cited by examiner]
US 20110066114A1 · McDown et al. · 2011 [cited by applicant]
US 20110288491A1 · Newman et al. · 2011 [cited by applicant]
US 20130041321A1 · Cross et al. · 2013 [cited by applicant]
US 20130211338A1 · Roberts et al. · 2013 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20190374717A1 · Swanson et al. · 2019 [cited by applicant]
US 20200384213A1 · Riedel et al. · 2020 [cited by applicant]
US 20240350749A1 · Riedel et al. · 2024 [cited by applicant]
US 20240350751A1 · Riedel et al. · 2024 [cited by applicant]
CN 1856333A · 2006 [cited by applicant]
CN 101014379A · 2007 [cited by applicant]
CN 102176937A · 2011 [cited by applicant]
CN 102470219A · 2012 [cited by applicant]
JP 2010501295A · 2010 [cited by applicant]
JP 2011512195A · 2011 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2009102596A2 · 2009 [cited by applicant]
WO WO2009114777A1 · 2009 [cited by applicant]
WO WO2010136077A1 · 2010 [cited by applicant]
WO WO2011092524A2 · 2011 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2012000837A1 · 2012 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2013/070582, dated Apr. 21, 2015, 6 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2013/070582, dated Oct. 29, 2013, 8 pages. [cited by applicant]